Click for best price
Precision Cancer Diagnostic Tests Market Size, Share 2024
| Market size in 2023 |
US$ 3912.3 million
|
Forecast Market size by 2030 |
US$ 9543.7 million
|
| Growth Rate |
CAGR of 13.2% |
Number of Pages |
147 Pages |
This research report provides a comprehensive analysis of the Precision Cancer Diagnostic Tests market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Precision Cancer Diagnostic Tests market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Precision Cancer Diagnostic Tests, challenges faced by the industry, and potential opportunities for market players.
The global Precision Cancer Diagnostic Tests market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Precision Cancer Diagnostic Tests market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Precision Cancer Diagnostic Tests market. Additionally, the growing consumer demand present avenues for market expansion.
The global Precision Cancer Diagnostic Tests market was valued at US$ 3912.3 million in 2023 and is projected to reach US$ 9543.7 million by 2030, at a CAGR of 13.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Precision Cancer Diagnostic Tests market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Precision Cancer Diagnostic Tests market.
Market Overview: The report provides a comprehensive overview of the Precision Cancer Diagnostic Tests market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Imaging, Molecular), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Precision Cancer Diagnostic Tests market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Precision Cancer Diagnostic Tests market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Precision Cancer Diagnostic Tests market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Precision Cancer Diagnostic Tests market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Precision Cancer Diagnostic Tests market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Precision Cancer Diagnostic Tests market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Precision Cancer Diagnostic Tests, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Precision Cancer Diagnostic Tests market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Precision Cancer Diagnostic Tests market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Imaging
- Molecular
- Histology/Cytology
- Tumor Marker Immunoassays
- POC Colon Cancer Tests
Market segment by Application
Global Precision Cancer Diagnostic Tests Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Abbott Laboratories
- Agilent Technologies
- Becton Dickinson and Company
- Bio-Rad Laboratories
- Biocartis N.V.
- Biocept
- bioMerieux SA
- Canon Medical Systems Corporation
- Cynvenio Biosystems
- Danaher Corporation
- Epigenomics AG
- Exosome Diagnostics
- Foundation Medicine
- General Electric Company
- Genomic Health
- Hologic
- Illumina
- Menarini Silicon Biosystems SpA
- Myriad Genetics
- NanoString Technologies
- Ortho Clinical Diagnostics
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Roche Holding AG
- Royal Philips N.V.
- Siemens AG
- Thermo Fisher Scientific
- Vela Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Diagnostic Tests, market overview.
Chapter 2: Global Precision Cancer Diagnostic Tests market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Diagnostic Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Diagnostic Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Precision Cancer Diagnostic Tests Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 3912.3 million
|
| Forecast Market size by 2030 |
US$ 9543.7 million
|
| Growth Rate |
CAGR of 13.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
147 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Diagnostic Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Diagnostic Tests Overall Market Size
2.1 Global Precision Cancer Diagnostic Tests Market Size: 2023 VS 2030
2.2 Global Precision Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Precision Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2023
3.5 Global Companies Precision Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Diagnostic Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precision Cancer Diagnostic Tests Market Size Markets, 2023 & 2030
4.1.2 Imaging
4.1.3 Molecular
4.1.4 Histology/Cytology
4.1.5 Tumor Marker Immunoassays
4.1.6 POC Colon Cancer Tests
4.2 By Type - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2019-2024
4.2.2 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2025-2030
4.2.3 By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Diagnostic Tests Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2019-2024
5.2.2 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2025-2030
5.2.3 By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Precision Cancer Diagnostic Tests Market Size, 2023 & 2030
6.2 By Region - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2019-2024
6.2.2 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2025-2030
6.2.3 By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Precision Cancer Diagnostic Tests Revenue, 2019-2030
6.3.2 US Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.3.3 Canada Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.3.4 Mexico Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Diagnostic Tests Revenue, 2019-2030
6.4.2 Germany Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.3 France Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.4 U.K. Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.5 Italy Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.6 Russia Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.7 Nordic Countries Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.4.8 Benelux Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Diagnostic Tests Revenue, 2019-2030
6.5.2 China Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.5.3 Japan Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.5.4 South Korea Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.5.5 Southeast Asia Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.5.6 India Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Precision Cancer Diagnostic Tests Revenue, 2019-2030
6.6.2 Brazil Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.6.3 Argentina Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, 2019-2030
6.7.2 Turkey Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.7.3 Israel Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.7.4 Saudi Arabia Precision Cancer Diagnostic Tests Market Size, 2019-2030
6.7.5 UAE Precision Cancer Diagnostic Tests Market Size, 2019-2030
7 Precision Cancer Diagnostic Tests Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
7.1.4 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Company Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Major Product Offerings
7.2.4 Agilent Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.2.5 Agilent Technologies Key News & Latest Developments
7.3 Becton Dickinson and Company
7.3.1 Becton Dickinson and Company Company Summary
7.3.2 Becton Dickinson and Company Business Overview
7.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Major Product Offerings
7.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.3.5 Becton Dickinson and Company Key News & Latest Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Company Summary
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
7.4.4 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.4.5 Bio-Rad Laboratories Key News & Latest Developments
7.5 Biocartis N.V.
7.5.1 Biocartis N.V. Company Summary
7.5.2 Biocartis N.V. Business Overview
7.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.5.4 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.5.5 Biocartis N.V. Key News & Latest Developments
7.6 Biocept
7.6.1 Biocept Company Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Precision Cancer Diagnostic Tests Major Product Offerings
7.6.4 Biocept Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.6.5 Biocept Key News & Latest Developments
7.7 bioMerieux SA
7.7.1 bioMerieux SA Company Summary
7.7.2 bioMerieux SA Business Overview
7.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Major Product Offerings
7.7.4 bioMerieux SA Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.7.5 bioMerieux SA Key News & Latest Developments
7.8 Canon Medical Systems Corporation
7.8.1 Canon Medical Systems Corporation Company Summary
7.8.2 Canon Medical Systems Corporation Business Overview
7.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Major Product Offerings
7.8.4 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.8.5 Canon Medical Systems Corporation Key News & Latest Developments
7.9 Cynvenio Biosystems
7.9.1 Cynvenio Biosystems Company Summary
7.9.2 Cynvenio Biosystems Business Overview
7.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Major Product Offerings
7.9.4 Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.9.5 Cynvenio Biosystems Key News & Latest Developments
7.10 Danaher Corporation
7.10.1 Danaher Corporation Company Summary
7.10.2 Danaher Corporation Business Overview
7.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Major Product Offerings
7.10.4 Danaher Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.10.5 Danaher Corporation Key News & Latest Developments
7.11 Epigenomics AG
7.11.1 Epigenomics AG Company Summary
7.11.2 Epigenomics AG Business Overview
7.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Major Product Offerings
7.11.4 Epigenomics AG Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.11.5 Epigenomics AG Key News & Latest Developments
7.12 Exosome Diagnostics
7.12.1 Exosome Diagnostics Company Summary
7.12.2 Exosome Diagnostics Business Overview
7.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.12.4 Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.12.5 Exosome Diagnostics Key News & Latest Developments
7.13 Foundation Medicine
7.13.1 Foundation Medicine Company Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Major Product Offerings
7.13.4 Foundation Medicine Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.13.5 Foundation Medicine Key News & Latest Developments
7.14 General Electric Company
7.14.1 General Electric Company Company Summary
7.14.2 General Electric Company Business Overview
7.14.3 General Electric Company Precision Cancer Diagnostic Tests Major Product Offerings
7.14.4 General Electric Company Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.14.5 General Electric Company Key News & Latest Developments
7.15 Genomic Health
7.15.1 Genomic Health Company Summary
7.15.2 Genomic Health Business Overview
7.15.3 Genomic Health Precision Cancer Diagnostic Tests Major Product Offerings
7.15.4 Genomic Health Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.15.5 Genomic Health Key News & Latest Developments
7.16 Hologic
7.16.1 Hologic Company Summary
7.16.2 Hologic Business Overview
7.16.3 Hologic Precision Cancer Diagnostic Tests Major Product Offerings
7.16.4 Hologic Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.16.5 Hologic Key News & Latest Developments
7.17 Illumina
7.17.1 Illumina Company Summary
7.17.2 Illumina Business Overview
7.17.3 Illumina Precision Cancer Diagnostic Tests Major Product Offerings
7.17.4 Illumina Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.17.5 Illumina Key News & Latest Developments
7.18 Menarini Silicon Biosystems SpA
7.18.1 Menarini Silicon Biosystems SpA Company Summary
7.18.2 Menarini Silicon Biosystems SpA Business Overview
7.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Major Product Offerings
7.18.4 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.18.5 Menarini Silicon Biosystems SpA Key News & Latest Developments
7.19 Myriad Genetics
7.19.1 Myriad Genetics Company Summary
7.19.2 Myriad Genetics Business Overview
7.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Major Product Offerings
7.19.4 Myriad Genetics Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.19.5 Myriad Genetics Key News & Latest Developments
7.20 NanoString Technologies
7.20.1 NanoString Technologies Company Summary
7.20.2 NanoString Technologies Business Overview
7.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Major Product Offerings
7.20.4 NanoString Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.20.5 NanoString Technologies Key News & Latest Developments
7.21 Ortho Clinical Diagnostics
7.21.1 Ortho Clinical Diagnostics Company Summary
7.21.2 Ortho Clinical Diagnostics Business Overview
7.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.21.4 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.21.5 Ortho Clinical Diagnostics Key News & Latest Developments
7.22 QIAGEN N.V.
7.22.1 QIAGEN N.V. Company Summary
7.22.2 QIAGEN N.V. Business Overview
7.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.22.4 QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.22.5 QIAGEN N.V. Key News & Latest Developments
7.23 Randox Laboratories Ltd.
7.23.1 Randox Laboratories Ltd. Company Summary
7.23.2 Randox Laboratories Ltd. Business Overview
7.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Major Product Offerings
7.23.4 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.23.5 Randox Laboratories Ltd. Key News & Latest Developments
7.24 Roche Holding AG
7.24.1 Roche Holding AG Company Summary
7.24.2 Roche Holding AG Business Overview
7.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Major Product Offerings
7.24.4 Roche Holding AG Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.24.5 Roche Holding AG Key News & Latest Developments
7.25 Royal Philips N.V.
7.25.1 Royal Philips N.V. Company Summary
7.25.2 Royal Philips N.V. Business Overview
7.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.25.4 Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.25.5 Royal Philips N.V. Key News & Latest Developments
7.26 Siemens AG
7.26.1 Siemens AG Company Summary
7.26.2 Siemens AG Business Overview
7.26.3 Siemens AG Precision Cancer Diagnostic Tests Major Product Offerings
7.26.4 Siemens AG Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.26.5 Siemens AG Key News & Latest Developments
7.27 Thermo Fisher Scientific
7.27.1 Thermo Fisher Scientific Company Summary
7.27.2 Thermo Fisher Scientific Business Overview
7.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Major Product Offerings
7.27.4 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.27.5 Thermo Fisher Scientific Key News & Latest Developments
7.28 Vela Diagnostics
7.28.1 Vela Diagnostics Company Summary
7.28.2 Vela Diagnostics Business Overview
7.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.28.4 Vela Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2019-2024)
7.28.5 Vela Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Diagnostic Tests Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Diagnostic Tests Market Drivers in Global Market
Table 3. Precision Cancer Diagnostic Tests Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Diagnostic Tests in Global Market
Table 5. Top Precision Cancer Diagnostic Tests Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Precision Cancer Diagnostic Tests Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Precision Cancer Diagnostic Tests Revenue Share by Companies, 2019-2024
Table 8. Global Companies Precision Cancer Diagnostic Tests Product Type
Table 9. List of Global Tier 1 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Precision Cancer Diagnostic Tests Product Offerings
Table 32. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Agilent Technologies Company Summary
Table 35. Agilent Technologies Precision Cancer Diagnostic Tests Product Offerings
Table 36. Agilent Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 37. Agilent Technologies Key News & Latest Developments
Table 38. Becton Dickinson and Company Company Summary
Table 39. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Offerings
Table 40. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 41. Becton Dickinson and Company Key News & Latest Developments
Table 42. Bio-Rad Laboratories Company Summary
Table 43. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Offerings
Table 44. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 45. Bio-Rad Laboratories Key News & Latest Developments
Table 46. Biocartis N.V. Company Summary
Table 47. Biocartis N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 48. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 49. Biocartis N.V. Key News & Latest Developments
Table 50. Biocept Company Summary
Table 51. Biocept Precision Cancer Diagnostic Tests Product Offerings
Table 52. Biocept Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 53. Biocept Key News & Latest Developments
Table 54. bioMerieux SA Company Summary
Table 55. bioMerieux SA Precision Cancer Diagnostic Tests Product Offerings
Table 56. bioMerieux SA Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 57. bioMerieux SA Key News & Latest Developments
Table 58. Canon Medical Systems Corporation Company Summary
Table 59. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Offerings
Table 60. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 61. Canon Medical Systems Corporation Key News & Latest Developments
Table 62. Cynvenio Biosystems Company Summary
Table 63. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Offerings
Table 64. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 65. Cynvenio Biosystems Key News & Latest Developments
Table 66. Danaher Corporation Company Summary
Table 67. Danaher Corporation Precision Cancer Diagnostic Tests Product Offerings
Table 68. Danaher Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 69. Danaher Corporation Key News & Latest Developments
Table 70. Epigenomics AG Company Summary
Table 71. Epigenomics AG Precision Cancer Diagnostic Tests Product Offerings
Table 72. Epigenomics AG Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 73. Epigenomics AG Key News & Latest Developments
Table 74. Exosome Diagnostics Company Summary
Table 75. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 76. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 77. Exosome Diagnostics Key News & Latest Developments
Table 78. Foundation Medicine Company Summary
Table 79. Foundation Medicine Precision Cancer Diagnostic Tests Product Offerings
Table 80. Foundation Medicine Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 81. Foundation Medicine Key News & Latest Developments
Table 82. General Electric Company Company Summary
Table 83. General Electric Company Precision Cancer Diagnostic Tests Product Offerings
Table 84. General Electric Company Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 85. General Electric Company Key News & Latest Developments
Table 86. Genomic Health Company Summary
Table 87. Genomic Health Precision Cancer Diagnostic Tests Product Offerings
Table 88. Genomic Health Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 89. Genomic Health Key News & Latest Developments
Table 90. Hologic Company Summary
Table 91. Hologic Precision Cancer Diagnostic Tests Product Offerings
Table 92. Hologic Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 93. Hologic Key News & Latest Developments
Table 94. Illumina Company Summary
Table 95. Illumina Precision Cancer Diagnostic Tests Product Offerings
Table 96. Illumina Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 97. Illumina Key News & Latest Developments
Table 98. Menarini Silicon Biosystems SpA Company Summary
Table 99. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Offerings
Table 100. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 101. Menarini Silicon Biosystems SpA Key News & Latest Developments
Table 102. Myriad Genetics Company Summary
Table 103. Myriad Genetics Precision Cancer Diagnostic Tests Product Offerings
Table 104. Myriad Genetics Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 105. Myriad Genetics Key News & Latest Developments
Table 106. NanoString Technologies Company Summary
Table 107. NanoString Technologies Precision Cancer Diagnostic Tests Product Offerings
Table 108. NanoString Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 109. NanoString Technologies Key News & Latest Developments
Table 110. Ortho Clinical Diagnostics Company Summary
Table 111. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 112. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 113. Ortho Clinical Diagnostics Key News & Latest Developments
Table 114. QIAGEN N.V. Company Summary
Table 115. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 116. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 117. QIAGEN N.V. Key News & Latest Developments
Table 118. Randox Laboratories Ltd. Company Summary
Table 119. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Offerings
Table 120. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 121. Randox Laboratories Ltd. Key News & Latest Developments
Table 122. Roche Holding AG Company Summary
Table 123. Roche Holding AG Precision Cancer Diagnostic Tests Product Offerings
Table 124. Roche Holding AG Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 125. Roche Holding AG Key News & Latest Developments
Table 126. Royal Philips N.V. Company Summary
Table 127. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 128. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 129. Royal Philips N.V. Key News & Latest Developments
Table 130. Siemens AG Company Summary
Table 131. Siemens AG Precision Cancer Diagnostic Tests Product Offerings
Table 132. Siemens AG Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 133. Siemens AG Key News & Latest Developments
Table 134. Thermo Fisher Scientific Company Summary
Table 135. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Offerings
Table 136. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 137. Thermo Fisher Scientific Key News & Latest Developments
Table 138. Vela Diagnostics Company Summary
Table 139. Vela Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 140. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn) & (2019-2024)
Table 141. Vela Diagnostics Key News & Latest Developments
List of Figures
Figure 1. Precision Cancer Diagnostic Tests Segment by Type in 2023
Figure 2. Precision Cancer Diagnostic Tests Segment by Application in 2023
Figure 3. Global Precision Cancer Diagnostic Tests Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Diagnostic Tests Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Precision Cancer Diagnostic Tests Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2023
Figure 8. By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 9. By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 10. By Type - Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 12. By Application - Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 14. By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 15. By Country - North America Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 16. US Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 20. Germany Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 21. France Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 28. China Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 32. India Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 34. Brazil Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue Market Share, 2019-2030
Figure 37. Turkey Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Agilent Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Biocept Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. bioMerieux SA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Danaher Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Epigenomics AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Foundation Medicine Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. General Electric Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Genomic Health Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Hologic Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Illumina Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Myriad Genetics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. NanoString Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 61. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 62. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 63. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 64. Roche Holding AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 65. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 66. Siemens AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 67. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 68. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
